Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors

Musaffe Tuna, Christopher I. Amos, Gordon Mills

    Research output: Contribution to journalReview article

    Abstract

    Recurrent fusion transcripts, which are one of the characteristic hallmarks of cancer, arise either from chromosomal rearrangements or from transcriptional errors in splicing. DNA rearrangements include intrachromosomal or interchromosomal translocation, tandem duplication, deletion, inversion, or result from chromothripsis, which causes complex rearrangements. In addition, fusion proteins can be created through transcriptional read-through. Fusion genes can be transcribed to fusion transcripts and translated to chimeric proteins, with many having demonstrated transforming activities through multiple mechanisms in cells. Fusion proteins represent novel therapeutic targets and diagnostic biomarkers of diagnosis, disease status, or progression. This review focuses on the mechanisms underlying the formation of oncogenic fusion genes and transcripts and their impact on the pathobiology of epithelial tumors.

    Original languageEnglish (US)
    Pages (from-to)2095-2111
    Number of pages17
    JournalOncotarget
    Volume10
    Issue number21
    StatePublished - Jan 1 2019

    Fingerprint

    Gene Fusion
    Neoplasms
    Proteins
    Gene Rearrangement
    Biomarkers
    Therapeutics
    Chromothripsis

    Keywords

    • Epithelial tumors
    • Fusion genes
    • Fusion transcripts
    • Mechanisms
    • Pathobiology

    ASJC Scopus subject areas

    • Oncology

    Cite this

    Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors. / Tuna, Musaffe; Amos, Christopher I.; Mills, Gordon.

    In: Oncotarget, Vol. 10, No. 21, 01.01.2019, p. 2095-2111.

    Research output: Contribution to journalReview article

    Tuna, Musaffe ; Amos, Christopher I. ; Mills, Gordon. / Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors. In: Oncotarget. 2019 ; Vol. 10, No. 21. pp. 2095-2111.
    @article{1104224c733a45d69bed71759d8d3367,
    title = "Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors",
    abstract = "Recurrent fusion transcripts, which are one of the characteristic hallmarks of cancer, arise either from chromosomal rearrangements or from transcriptional errors in splicing. DNA rearrangements include intrachromosomal or interchromosomal translocation, tandem duplication, deletion, inversion, or result from chromothripsis, which causes complex rearrangements. In addition, fusion proteins can be created through transcriptional read-through. Fusion genes can be transcribed to fusion transcripts and translated to chimeric proteins, with many having demonstrated transforming activities through multiple mechanisms in cells. Fusion proteins represent novel therapeutic targets and diagnostic biomarkers of diagnosis, disease status, or progression. This review focuses on the mechanisms underlying the formation of oncogenic fusion genes and transcripts and their impact on the pathobiology of epithelial tumors.",
    keywords = "Epithelial tumors, Fusion genes, Fusion transcripts, Mechanisms, Pathobiology",
    author = "Musaffe Tuna and Amos, {Christopher I.} and Gordon Mills",
    year = "2019",
    month = "1",
    day = "1",
    language = "English (US)",
    volume = "10",
    pages = "2095--2111",
    journal = "Oncotarget",
    issn = "1949-2553",
    publisher = "Impact Journals",
    number = "21",

    }

    TY - JOUR

    T1 - Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors

    AU - Tuna, Musaffe

    AU - Amos, Christopher I.

    AU - Mills, Gordon

    PY - 2019/1/1

    Y1 - 2019/1/1

    N2 - Recurrent fusion transcripts, which are one of the characteristic hallmarks of cancer, arise either from chromosomal rearrangements or from transcriptional errors in splicing. DNA rearrangements include intrachromosomal or interchromosomal translocation, tandem duplication, deletion, inversion, or result from chromothripsis, which causes complex rearrangements. In addition, fusion proteins can be created through transcriptional read-through. Fusion genes can be transcribed to fusion transcripts and translated to chimeric proteins, with many having demonstrated transforming activities through multiple mechanisms in cells. Fusion proteins represent novel therapeutic targets and diagnostic biomarkers of diagnosis, disease status, or progression. This review focuses on the mechanisms underlying the formation of oncogenic fusion genes and transcripts and their impact on the pathobiology of epithelial tumors.

    AB - Recurrent fusion transcripts, which are one of the characteristic hallmarks of cancer, arise either from chromosomal rearrangements or from transcriptional errors in splicing. DNA rearrangements include intrachromosomal or interchromosomal translocation, tandem duplication, deletion, inversion, or result from chromothripsis, which causes complex rearrangements. In addition, fusion proteins can be created through transcriptional read-through. Fusion genes can be transcribed to fusion transcripts and translated to chimeric proteins, with many having demonstrated transforming activities through multiple mechanisms in cells. Fusion proteins represent novel therapeutic targets and diagnostic biomarkers of diagnosis, disease status, or progression. This review focuses on the mechanisms underlying the formation of oncogenic fusion genes and transcripts and their impact on the pathobiology of epithelial tumors.

    KW - Epithelial tumors

    KW - Fusion genes

    KW - Fusion transcripts

    KW - Mechanisms

    KW - Pathobiology

    UR - http://www.scopus.com/inward/record.url?scp=85063665474&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85063665474&partnerID=8YFLogxK

    M3 - Review article

    VL - 10

    SP - 2095

    EP - 2111

    JO - Oncotarget

    JF - Oncotarget

    SN - 1949-2553

    IS - 21

    ER -